STOP-BANG screener vs objective obstructive sleep apnea testing among younger veterans with PTSD and insomnia: STOP-BANG does not sufficiently detect risk

Lyons, Robert; Barbir, Lara A.; Owens, Robert L.; Colvonen, Peter J.

doi:10.5664/jcsm.9498

Cited by 7 publications

(3 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…First, as previously mentioned, symptom severity does not discriminate between OSA positive/negative. Second, there is increasing evidence that self-report questionnaires for “high risk of OSA” are not accurate as screeners for veterans or PTSD (Kunisaki et al, 2014; Lyons et al, 2021; McMahon et al, 2017). Together, there are no predictable visual, symptomatic, or self-report screeners to indicate who is in need of PAP treatment.…”

Section: Discussionmentioning

confidence: 99%

“…Second, there is substantial evidence that OSA is increasing in younger veterans with co-occurring mental health disorders who do not have the classic risk factors (e.g., older age, overweight or obese per BMI), so OSA becomes difficult to identify (Colvonen et al, 2015; Rezaeitalab et al, 2018; Williams et al, 2015). As such, self-report OSA screening questionnaires, like the STOP-BANG or Berlin, that rely heavily on age, blood pressure, and BMI, are shown to be poor predictors of OSA in all veterans (Kunisaki et al, 2014; McMahon et al, 2017) as well as specifically among veterans with PTSD (Lyons et al, 2021). This suggests the need for objective OSA diagnostic testing among veterans.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Diagnosing obstructive sleep apnea in a residential treatment program for veterans with substance use disorder and PTSD.

Colvonen¹,

Rivera²,

Straus³

et al. 2022

Psychological Trauma: Theory, Research, Practice, and

Self Cite

View full text Add to dashboard Cite

Background: Obstructive sleep apnea (OSA) is often comorbid with both substance use disorders (SUD) and posttraumatic stress disorder (PTSD), yet frequently goes undiagnosed and untreated. We present data on the feasibility and acceptability of objective OSA diagnosis procedures, findings on OSA prevalence, and the relationship between OSA and baseline SUD/PTSD symptoms among veterans in residential treatment for comorbid PTSD/SUD. Methods: Participants were 47 veterans admitted to residential PTSD/SUD treatment. Participants completed questionnaires assessing PTSD and sleep symptoms, and filled out a sleep diary for seven days. Apnea-hypopnea index (AHI) was recorded using the overnight Home Sleep Apnea test (HSAT; OSA was diagnosed with AHI $ 5). Results: Objective OSA diagnostic testing was successfully completed in 95.7% of participants. Of the 45 veterans who went through HSAT, 46.7% had no OSA, 35.6% received a new OSA diagnosis, and 8.9% were previously diagnosed with OSA and were using positive airway pressure treatment (PAP); an additional 8.9% were previously diagnosed with OSA, reconfirmed with the HSAT, but were not using PAP. One hundred percent of respondents during follow-up deemed the testing protocol's usefulness as "Good" or "Excellent." Conclusion: OSA diagnostic testing on the residential unit was feasible and acceptable by participants and was effective in diagnosing OSA. OSA testing should be considered for everyone entering a SUD and PTSD residential unit. Clinical Impact StatementObstructive sleep apnea (OSA) is very often comorbid with both posttraumatic stress disorder (PTSD) and substance use disorders (SUD). Unfortunately, due to the limitations of self-report OSA screeners and atypical presentation of OSA in individuals with SUD/PTSD, OSA often goes undiagnosed for individuals with SUD/PTSD. Our study found that OSA diagnostic testing was feasible and acceptable to participants in a residential treatment program for SUD/PTSD, and effective in diagnosing OSA. Diagnosing OSA on a residential unit for SUD/PTSD is a necessary first step to treating OSA and may help improve long-term outcomes for individuals with SUD/PTSD.

show abstract

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

Diagnosing obstructive sleep apnea in a residential treatment program for veterans with substance use disorder and PTSD.

Colvonen¹,

Rivera²,

Straus³

et al. 2022

Psychological Trauma: Theory, Research, Practice, and

Self Cite

View full text Add to dashboard Cite

show abstract

“…People having three risk factors for OSA (BMI > 30, hypertension, snoring) were then referred to the Sleep Apnea Center for further evaluation. In order to improve efficiency of the screening, we did not use common screening tools like STOP-BANG, as in some studies, it lacked good performance in younger patients [ 24 ]. Thus, we used two objective risk factors of OSA (high BMI, verified hypertension) with one subjective factor, snoring, which was shown to be more associated with moderate/severe OSA than other risk factors [ 25 ].…”

Section: Methodsmentioning

confidence: 99%

Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study

Yakovlev

Teplyakov

Гракова

et al. 2023

Life

View full text Add to dashboard Cite

Heart failure with preserved ejection fraction (HFpEF) and obstructive sleep apnea (OSA) frequently co-occur and this comorbidity represents a separate phenotype of HFpEF. While many research attempts are focused on biomarkers of HFpEF, currently, there is a lack of validated biomarkers of HFpEF and OSA. In this study, we aimed to evaluate prognostic significance of several serum cytokines in patients with HFpEF and OSA. The patients with HFpEF and OSA were recruited from the Sleep Apnea Center of Novosibirsk, Russian Federation and followed up for 12 months. The main analyzed outcomes were five-point major adverse cardiovascular events (MACE) and the 6-min walk test (6MWT). The analyzed cytokines were circulating IL-6, IL-10, and VEGF measured at baseline. We recruited 77 male patients with HFpEF and OSA, the data of 71 patients were available for analyses. Patients who developed MACE had four-fold elevated concentrations of serum IL-10. There was no association between baseline cytokine levels and longitudinal changes in 6MWT. Circulating IL-10 levels are positively associated with MACE in men with HFpEF and OSA and thus may be a potential prognostic biomarker in this subgroup of patients. These results should be confirmed in larger studies encompassing both males and females.

show abstract

Clinical Characteristics and Treatment Efficacy for Co-Morbid Insomnia and Sleep Apnea (COMISA): Evidence from Qualitative and Quantitative Analysis

Liu,

Zang,

et al. 2024

Behavioral Sleep Medicine

View full text Add to dashboard Cite

STOP-BANG screener vs objective obstructive sleep apnea testing among younger veterans with PTSD and insomnia: STOP-BANG does not sufficiently detect risk

Cited by 7 publications

References 50 publications

Diagnosing obstructive sleep apnea in a residential treatment program for veterans with substance use disorder and PTSD.

Diagnosing obstructive sleep apnea in a residential treatment program for veterans with substance use disorder and PTSD.

Serum Cytokines as Biomarkers in Heart Failure with Preserved Ejection Fraction and Sleep Apnea: A Prospective Cohort Study

Clinical Characteristics and Treatment Efficacy for Co-Morbid Insomnia and Sleep Apnea (COMISA): Evidence from Qualitative and Quantitative Analysis

Contact Info

Product

Resources

About